BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36462515)

  • 1. Cardiovascular disease prevention and mortality across 1 million urban populations in China: data from a nationwide population-based study.
    Zhang X; Lu J; Yang Y; Cui J; Zhang X; Xu W; Song L; Wu C; Wang Q; Wang Y; Wang R; Li X
    Lancet Public Health; 2022 Dec; 7(12):e1041-e1050. PubMed ID: 36462515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Socioeconomic Gender Inequality on Sex Disparities in Prevention and Outcome of Cardiovascular Disease: Data From a Nationwide Population Cohort in China.
    Wang Y; Tian A; Wu C; Lu J; Chen B; Yang Y; Zhang X; Zhang X; Cui J; Xu W; Song L; Guo W; Wang R; Li X; Hu S
    J Am Heart Assoc; 2023 Oct; 12(20):e030203. PubMed ID: 37804201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
    Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
    Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
    Marcus ME; Manne-Goehler J; Theilmann M; Farzadfar F; Moghaddam SS; Keykhaei M; Hajebi A; Tschida S; Lemp JM; Aryal KK; Dunn M; Houehanou C; Bahendeka S; Rohloff P; Atun R; Bärnighausen TW; Geldsetzer P; Ramirez-Zea M; Chopra V; Heisler M; Davies JI; Huffman MD; Vollmer S; Flood D
    Lancet Glob Health; 2022 Mar; 10(3):e369-e379. PubMed ID: 35180420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer diagnosis and care among rural-to-urban migrants in China.
    Myerson R; Lu T; Yuan Y; Liu GG
    BMJ Glob Health; 2019; 4(6):e001923. PubMed ID: 31908866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the relationship between migrants' purchasing of commercial medical insurance and urbanisation in China.
    Liu J; Chen H; Chen Y; Li Z
    BMC Health Serv Res; 2018 Sep; 18(1):679. PubMed ID: 30176868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic disparity in mortality and the burden of cardiovascular disease: analysis of the Prospective Urban Rural Epidemiology (PURE)-China cohort study.
    Zhu Y; Wang Y; Shrikant B; Tse LA; Zhao Y; Liu Z; Wang C; Xiang Q; Rangarajan S; Li S; Liu W; Li M; Han A; Tang J; Hu B; Yusuf S; Li W;
    Lancet Public Health; 2023 Dec; 8(12):e968-e977. PubMed ID: 38000890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in urban/rural inequalities in cardiovascular risk bio-markers among Chinese adolescents in two decades of urbanisation: 1991-2011.
    Zhang N
    Int J Equity Health; 2018 Jul; 17(1):101. PubMed ID: 29996851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study.
    ; Zhou T; Wang Y; Zhang H; Wu C; Tian N; Cui J; Bai X; Yang Y; Zhang X; Lu Y; Spatz ES; Ross JS; Krumholz HM; Lu J; Li X; Hu S
    Lancet Glob Health; 2023 Jan; 11(1):e83-e94. PubMed ID: 36521957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study.
    Fan J; Yu C; Guo Y; Bian Z; Sun Z; Yang L; Chen Y; Du H; Li Z; Lei Y; Sun D; Clarke R; Chen J; Chen Z; Lv J; Li L;
    Lancet Public Health; 2020 Dec; 5(12):e650-e660. PubMed ID: 33271078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.
    Khatib R; McKee M; Shannon H; Chow C; Rangarajan S; Teo K; Wei L; Mony P; Mohan V; Gupta R; Kumar R; Vijayakumar K; Lear SA; Diaz R; Avezum A; Lopez-Jaramillo P; Lanas F; Yusoff K; Ismail N; Kazmi K; Rahman O; Rosengren A; Monsef N; Kelishadi R; Kruger A; Puoane T; Szuba A; Chifamba J; Temizhan A; Dagenais G; Gafni A; Yusuf S;
    Lancet; 2016 Jan; 387(10013):61-9. PubMed ID: 26498706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
    Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials.
    Bangalore S; Fakheri R; Toklu B; Ogedegbe G; Weintraub H; Messerli FH
    Mayo Clin Proc; 2016 Jan; 91(1):51-60. PubMed ID: 26763511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of the Number of Men Who Have Sex with Men among Rural-To-Urban Migrants with Non-Migrant Rural and Urban Residents in Wuhan, China: A GIS/GPS-Assisted Random Sample Survey Study.
    Chen X; Yu B; Zhou D; Zhou W; Gong J; Li S; Stanton B
    PLoS One; 2015; 10(8):e0134712. PubMed ID: 26241900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.